Orion Oyj has signed a loan agreement of EUR 100 million with the European Investment Bank in Espoo. The financing is intended to support Orion's investments in research and development, thus supporting the creation of new medicines, in the fields of oncology and neurological and respiratory diseases. Some of the main focus areas for the project's research are prostate cancer, other solid tumours and diseases such as Amyotrophic Lateral Sclerosis and respiratory therapy - treatment of asthma and Chronic Obstructive Pulmonary Disease. The project will operate until 2020 and will be mainly conducted at Orion's research centres in Finland.